Skip to content
Screener

Corvel CRVL Financing Cash Flow

Financing Cash Flow at other companies

Arthur J. Gallagher logo
Arthur J. GallagherAJG
$1.25B+496%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-$10.99M
Claritev Corporation logo
Claritev CorporationCTEV
$98.93M+35.2%
CareCloud, Inc. logo
CareCloud, Inc.CCLD
$4.47M+354%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
-$790K-142%
Cencora logo
CencoraCOR
$3.98B

Other financials

Income statement

See full
Revenue$259.9M+10.7%
Gross profit$67.8M+19.4%
Net income$32.2M+18.3%
EPS (diluted)$0.63+21.2%

Balance sheet

See full
Cash & equivalents$255.9M+26.7%
Total debt$28.4M+3.6%
Total equity$408.9M+19.4%
Total assets$689.7M+15.4%

Cash flow

See full
Operating cash flow$49.9M-9.3%
CapEx$6.8M-55.8%
Free cash flow$43.1M+8.9%

Valuation

See full
Market cap$3.19B-28.9%
Enterprise value$2.96B-31.3%
P/E27.7×-16.8×
P/S3.2×-1.6×

Profitability

See full
Gross margin24.8%+1.0pp
Net margin11.7%+0.7pp
FCF margin11.6%+0.9pp

Returns & leverage

See full
Return on equity30.7%-2.6pp
Debt / equity0.1×0.0×
Current ratio1.9×+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Corvel’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:30 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001193125-26-338216
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025
Cash Flows from Financing Activities
Purchase of treasury stock(21,968,000)(9,617,000)
Proceeds from exercise of common stock options1,694,0001,510,000
Net cash used in financing activities(20,274,000)(8,107,000)
Increase in cash and cash equivalents22,811,00031,441,000
Cash and cash equivalents at beginning of period233,072,000170,584,000
Cash and cash equivalents at end of period$255,883,000$202,025,000
Supplemental Cash Flow Information:

ITEM 1 – FINANCIAL STATEMENTS

FAQ

What is Corvel's financing cash flow?
Corvel (CRVL) reported financing cash flow of -$20.27M in Q2 2026.
How has Corvel's financing cash flow changed year-over-year?
Corvel's financing cash flow decreased by 150.1% year-over-year, from -$8.11M to -$20.27M.
What is the long-term trend for Corvel's financing cash flow?
Over 4 years (2022 to 2026), Corvel's financing cash flow has grown at a -12.0% compound annual growth rate (CAGR), from -$79.62M to -$47.8M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Corvel's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude